Literature DB >> 22903150

The anatomical and cellular basis of immune surveillance in the central nervous system.

Richard M Ransohoff1, Britta Engelhardt.   

Abstract

The central nervous system (CNS) comprises the brain, spinal cord, optic nerves and retina, and contains post-mitotic, delicate cells. As the rigid coverings of the CNS render swelling dangerous and destructive, inflammatory reactions must be carefully controlled in CNS tissues. Nevertheless, effector immune responses that protect the host during CNS infection still occur in the CNS. Here, we describe the anatomical and cellular basis of immune surveillance in the CNS, and explain how this shapes the unique immunology of these tissues. The Review focuses principally on insights gained from the study of autoimmune responses in the CNS and to a lesser extent on models of infectious disease. Furthermore, we propose a new model to explain how antigen-specific T cell responses occur in the CNS.

Entities:  

Mesh:

Year:  2012        PMID: 22903150     DOI: 10.1038/nri3265

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  97 in total

1.  Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis.

Authors:  Eileen J McMahon; Samantha L Bailey; Carol Vanderlugt Castenada; Hanspeter Waldner; Stephen D Miller
Journal:  Nat Med       Date:  2005-02-27       Impact factor: 53.440

2.  Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells.

Authors:  Ingunn M Stromnes; Lauren M Cerretti; Denny Liggitt; Robert A Harris; Joan M Goverman
Journal:  Nat Med       Date:  2008-02-17       Impact factor: 53.440

3.  Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis.

Authors:  Birgit Obermeier; Reinhard Mentele; Joachim Malotka; Josef Kellermann; Tania Kümpfel; Hartmut Wekerle; Friedrich Lottspeich; Reinhard Hohlfeld; Klaus Dornmair
Journal:  Nat Med       Date:  2008-05-18       Impact factor: 53.440

Review 4.  Origin, nature, and some functional considerations of intraventricular macrophages, with special reference to the epiplexus cells.

Authors:  E A Ling; C Kaur; J Lu
Journal:  Microsc Res Tech       Date:  1998-04-01       Impact factor: 2.769

5.  Chronic experimental allergic encephalomyelitis in guinea pigs induced by proteolipid protein.

Authors:  T Yoshimura; T Kunishita; K Sakai; M Endoh; T Namikawa; T Tabira
Journal:  J Neurol Sci       Date:  1985 May-Jun       Impact factor: 3.181

6.  Pericyte loss and microaneurysm formation in PDGF-B-deficient mice.

Authors:  P Lindahl; B R Johansson; P Levéen; C Betsholtz
Journal:  Science       Date:  1997-07-11       Impact factor: 47.728

7.  Gray matter atrophy in multiple sclerosis: a longitudinal study.

Authors:  Elizabeth Fisher; Jar-Chi Lee; Kunio Nakamura; Richard A Rudick
Journal:  Ann Neurol       Date:  2008-09       Impact factor: 10.422

8.  CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues.

Authors:  Ricardo Villares; Vanessa Cadenas; María Lozano; Luis Almonacid; Angel Zaballos; Carlos Martínez-A; Rosa Varona
Journal:  Eur J Immunol       Date:  2009-06       Impact factor: 5.532

9.  Initiation of immune responses in brain is promoted by local dendritic cells.

Authors:  Jozsef Karman; Changying Ling; Matyas Sandor; Zsuzsanna Fabry
Journal:  J Immunol       Date:  2004-08-15       Impact factor: 5.422

10.  Human cerebrospinal fluid contains CD4+ memory T cells expressing gut- or skin-specific trafficking determinants: relevance for immunotherapy.

Authors:  Pia Kivisäkk; Barbara Tucky; Tao Wei; James J Campbell; Richard M Ransohoff
Journal:  BMC Immunol       Date:  2006-07-07       Impact factor: 3.615

View more
  355 in total

Review 1.  Th17 cells in depression.

Authors:  Eléonore Beurel; Jeffrey A Lowell
Journal:  Brain Behav Immun       Date:  2017-08-03       Impact factor: 7.217

Review 2.  Neuroinflammation: Ways in Which the Immune System Affects the Brain.

Authors:  Richard M Ransohoff; Dorothy Schafer; Angela Vincent; Nathalie E Blachère; Amit Bar-Or
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

3.  Autoimmune encephalitis following haematopoietic stem cell transplant: a new clinical entity or a previously unrecognised one?

Authors:  Alasdair Bamford; Ming Lim
Journal:  Transl Pediatr       Date:  2015-10

Review 4.  The Bidirectional Relationship of Depression and Inflammation: Double Trouble.

Authors:  Eléonore Beurel; Marisa Toups; Charles B Nemeroff
Journal:  Neuron       Date:  2020-06-17       Impact factor: 17.173

Review 5.  Potential importance of B cells in aging and aging-associated neurodegenerative diseases.

Authors:  Arya Biragyn; Maria Aliseychik; Evgeny Rogaev
Journal:  Semin Immunopathol       Date:  2017-01-12       Impact factor: 9.623

Review 6.  PD-1 Inhibitors: Do they have a Future in the Treatment of Glioblastoma?

Authors:  Mustafa Khasraw; David A Reardon; Michael Weller; John H Sampson
Journal:  Clin Cancer Res       Date:  2020-06-11       Impact factor: 12.531

Review 7.  Are immune checkpoint blockade monoclonal antibodies active against CNS metastases from NSCLC?-current evidence and future perspectives.

Authors:  Grainne M O'Kane; Natasha B Leighl
Journal:  Transl Lung Cancer Res       Date:  2016-12

Review 8.  Contributions of monocytes to nervous system disorders.

Authors:  Juan Mauricio Garré; Guang Yang
Journal:  J Mol Med (Berl)       Date:  2018-07-21       Impact factor: 4.599

9.  Brain Perivascular Macrophages Initiate the Neurovascular Dysfunction of Alzheimer Aβ Peptides.

Authors:  Laibaik Park; Ken Uekawa; Lidia Garcia-Bonilla; Kenzo Koizumi; Michelle Murphy; Rose Pistik; Linda Younkin; Steven Younkin; Ping Zhou; George Carlson; Josef Anrather; Costantino Iadecola
Journal:  Circ Res       Date:  2017-05-17       Impact factor: 17.367

Review 10.  CD4 T cells in immunity and immunotherapy of Alzheimer's disease.

Authors:  Alon Monsonego; Anna Nemirovsky; Idan Harpaz
Journal:  Immunology       Date:  2013-08       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.